| Bid | Ask | |
| Price | n.a. | n.a. |
| Volume | n.a. | n.a. |
| Change compared with previous day | n.a. | n.a. |
| Time | n.a. | n.a. |
| Date | n.a. | n.a. |
| Currency | ||
| Nominal amount | ||
| Exchange | ||
| Life cycle | redeemed | |
| Daily high/low | n.a. / n.a. |
| All-time high/low | n.a. / n.a. |
| Performance of structured product since issue | |
| Performance of underlying since issue | n.a. |
| Risk | |
| SSPA VaR | |
| SSPA risk rating |
| Volatility | |
| 30-day volatility | |
| 100-day volatility |
| ZKB Barrier Reverse Convertible on worst of UBS Group AG/Helvetia Baloise Holding/Swiss Life Holding... 151092812 / CH1510928125 |
| 10.0404% p.a. ZKB Callable Barrier Reverse Convertible, 19.08.2027 on worst of NESN SE/NOVN SE/ROP S... 151093164 / CH1510931640 |
| ZKB Barrier Reverse Convertible auf UBS Group AG 151093281 / CH1510932812 |
| ZKB Barrier Reverse Convertible on worst of Novartis AG/Geberit AG/UBS Group AG 151092088 / CH1510920882 |
| ZKB Callable Barrier Reverse Convertible on worst of Nestlé AG/Barry Callebaut AG/UBS Group AG/EMS-C... 149283732 / CH1492837328 |